Silence Therapeutics plc - Multiplikator EV/Sales SLN

Simbol resmi perusahaan Silence Therapeutics PLC (SLN)

Management has strengthened its position through a proprietary siRNA platform for targeted gene silencing. The trajectory of Silence Therapeutics (SLN) valuation relative to revenue demonstrates the results of this strategy, where the value of 2140456.52 describes the current level. The business is based on the efficiency of RNA interference, generating revenue from licenses granted to pharma behemoths for hypertension therapy and the treatment of rare blood and heart pathologies.

SLN - Multiplikator EV/Sales Silence Therapeutics plc ing rentang 23.11.2025 - 20.11.2026

Rincian metrik keuangan lan pasar Silence Therapeutics plc (SLN)

Pambiji fundamental perusahaan:SLN (Silence Therapeutics)
Produk seri silence-therapeutics.com

Silence Therapeutics is advancing RNA therapeutics through strategic alliances, avoiding costly acquisitions. This indicator compares the total enterprise value to sales volume, eliminating the impact of leverage on the valuation. An analysis of the enterprise value-to-sales multiple reveals the actual market overvaluation relative to current revenues. Fluctuations in the chart reflect shifting phases of investment confidence in the platform. The stability of this metric confirms the resilience of the sponsored development model.

Analisis pesaing Silence Therapeutics

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|SRPT: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Twist Bioscience|TXG (10x Genomics) - Nilai perusahaan marang pendapatan|Intellia Therapeutics, Inc. (NTLA) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Stoke Therapeutics Inc|BLFS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan WVE (Wave Life Sciences Corp)|Rasio total nilai perusahaan marang pendapatan Maze Therapeutics Corp|Sionna Therapeutics Inc - Nilai perusahaan marang pendapatan|PRME (primemedicine.com) - Nilai perusahaan marang volume dodolan|TSHA - Rasio nilai perusahaan marang pendapatan|QURE (uniQure) - Rasio nilai perusahaan marang pendapatan|MeiraGTx Corp (MGTX) - Rasio nilai perusahaan marang pendapatan|Regenxbio - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan solidbio.com|Multiplikator nilai perusahaan marang pendapatan ocugen.com OCGN|Multiplikator EV/Sales PACB|Benitec - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Design Therapeutics DSGN|Multiplikator EV/Sales Rocket Pharmaceuticals RCKT|Nilai perusahaan marang volume dodolan 4D Molecular Corp|LXEO: Rasio nilai perusahaan marang pendapatan|KRRO (Korro Bio, Inc) - Nilai perusahaan marang pendapatan|Editas Medicine (EDIT) - Multiplikator EV/Sales|PRQR (ProQR Therapeutics) - Multiplikator EV/Sales|codexis.com (CDXS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales SGMO|Multiplikator EV/Sales Nautilus Biotechnology, Inc. (NAUT)|Multiplikator EV/Sales MGX (Metagenomi Inc.)|Nilai bisnis marang pendapatan DTIL|Generation Bio Co. - Multiplikator EV/Sales|BOLD: Rasio nilai perusahaan marang pendapatan|XCUR (Exicure, Inc.) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan IMNN|Rasio nilai perusahaan marang pendapatan RXi Pharmaceuticals|mustangbio.com (MBIO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan TransCode (RNAZ)|Bionano Genomics Inc. - Rasio nilai perusahaan marang pendapatan|Applied DNA Sciences - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan bluebirdbio.com (BLUE)|IPA - Rasio nilai perusahaan marang pendapatan|OMGA - Multiplikator EV/Sales|OMIC (Singular Genomics Systems, Inc.) - Nilai perusahaan marang pendapatan|Regulus Therapeutics Inc - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Syros Pharmaceuticals|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan